Bone is an endocrine organ that reaches out to other tissues, orchestrating responses that may have a role in pathology and physiology at distant sites. In 'Bench to Bedside', L. Darryl Quarles discusses recent studies showing how a feedback loop between the bone hormone FGF-23 and renal phosphate excretion and vitamin D metabolism is integrated with the classical PTH–vitamin D axis in chronic kidney disease (CKD). This new paradigm may change the diagnosis and treatment of disordered mineral homeostasis of people with CKD. A recent epidemiological study argues a mechanistic link between bone loss and atherosclerosis, maladies usually linked to aging. In 'Bedside to Bench', Sundeep Khosla discusses how this clinical study underpins research showing that mediators of inflammation and oxidative stress share common mechanisms that may lead to this calcium shift during aging.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Role of FGF/FGFR signaling in skeletal development and homeostasis: learning from mouse models
Bone Research Open Access 29 April 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Katsnelson, A. Nature 466, 914–915 (2010).
Quarles, L.D. J. Clin. Invest. 118, 3820–3828 (2008).
Liu, S. et al. J. Am. Soc. Nephrol. 17, 1305–1315 (2006).
Saji, F. et al. Am. J. Physiol. Renal Physiol. 299, F1212–F1217 (2010).
Samadfam, R. et al. Endocrinology 150, 4835–4845 (2009).
Weber, T.J. et al. J. Bone Miner. Res. 18, 1227–1234 (2003).
Komaba, H. & Fukagawa, M. Kidney Int. 77, 292–298 (2010).
Gutiérrez, O. et al. J. Am. Soc. Nephrol. 16, 2205–2215 (2005).
Hasegawa, H. et al. Kidney Int. 78, 975–980 (2010).
Sato, T. et al. Am. J. Kidney Dis. 44, 481–487 (2004).
Riminucci, M. et al. J. Clin. Invest. 112, 683–692 (2003).
Lavi-Moshayoff, V. et al. Am. J. Physiol. Renal Physiol. 299, F882–F889 (2010).
Ben-Dov, I.Z. et al. J. Clin. Invest. 117, 4003–4008 (2007).
Gutierrez, O.M. et al. N. Engl. J. Med. 359, 584–592 (2008).
Wetmore, J.B. et al. Clin. J. Am. Soc. Nephrol. 5, 110–116 (2010).
Tsuji, K. et al. J. Bone Miner. Res. 25, 1711–1723 (2010).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
L.D.C. is a consultant to Amgen, KAI Pharmaceuticals and Shire. He has also been a paid speaker for Amgen.
Rights and permissions
About this article
Cite this article
Quarles, L. 'Dem bones' are made for more than walking. Nat Med 17, 428–430 (2011). https://doi.org/10.1038/nm0411-428
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0411-428
This article is cited by
-
Molecular Control of Phosphorus Homeostasis and Precision Treatment of Hypophosphatemic Disorders
Current Molecular Biology Reports (2019)
-
Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23
Nature Reviews Drug Discovery (2016)
-
Plasma fibroblast growth factor 23 and risk of cardiovascular disease: results from the EPIC-Germany case-cohort study
European Journal of Epidemiology (2015)
-
Role of FGF/FGFR signaling in skeletal development and homeostasis: learning from mouse models
Bone Research (2014)
-
Novel Bone Endocrine Networks Integrating Mineral and Energy Metabolism
Current Osteoporosis Reports (2013)
